RxDoctor Payments Data

Emily Bellamy, PA

Medical · Clinton, MONPI 1114678505

Payments from drug & device makers

$1,074in general payments, 2019–2025

Across 56 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$194
  • Novartis$174
  • Amgen$103
  • Regeneron Healthcare Solutions, Inc.$99
  • Medtronic$80
  • Pfizer$69
  • plus $355 from 18 others

What the payments were for

  • Food & beverage$1,074100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,074 in reported general payments places this provider in the 65th percentile of 198 medical providers in Missouri.

See all medical providers in Missouri

Medicare billing

Part B allowed, 2024
$4,846
Medicare patients
58
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$62,979
Repatha SureclickEvolocumab31$46,573
JardianceEmpagliflozin43$30,824
XareltoRivaroxaban19$23,164
Ezetimibe124$2,417
Torsemide126$1,613
Metoprolol Succinate161$1,278
Diltiazem 24hr Er (Cd)Diltiazem Hcl34$957
Atorvastatin Calcium91$826
Rosuvastatin Calcium101$718
Diltiazem 24hr ErDiltiazem Hcl63$717
Losartan Potassium121$623
Potassium Chloride30$606
Nebivolol Hcl21$537
Flecainide Acetate27$525

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$62,97994 claims
Boehringer IngelheimJardiance$194$30,82443 claims
Johnson & JohnsonXarelto$14$23,16419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 198 medical providers in Missouri.

Other medical in Clinton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →